Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Asia Pacific Prostate Cancer Conference /
Lecture: Future strategies and targets for prostate cancer

1st - 2nd Mar 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.05.14
Views: 3557

Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany

Dr Kurt Miller from Berlin, Germany, looks ahead in prostate cancer. He reviews the drive for more personalised medicine and reviews biomarkers for partially prognostic and partially predictive markers, such as the composite score of LDH, neutrophil lymphocyte ratio and extent of metastases. He also considers the various genetic markers being explored, such as ERG. He then moves on to talk about potential new compounds, such as cabozantinib, OGX-011, PSMA ADC and bite molecules.

This video is sponsored by an educational grant from Janssen Asia Pacific, a pharmaceutical company of Johnson & Johnson

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation